Rifampicin-Induced Minimal Change Disease Is Improved after Cessation of Rifampicin without Steroid Therapy

There are several reports to demonstrate that rifampicin, a major anti-tuberculosis agent, is associated with some adverse renal effects, with a few cases of rifampicin-induced minimal change disease (MCD). In the present case, a 68-year-old female presented with nausea, vomiting, foamy urine, gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong Hyuk, Lee, Sul A, Jeong, Hyeon Joo, Yoo, Tae-Hyun, Kang, Shin-Wook, Oh, Hyung Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329376/
https://www.ncbi.nlm.nih.gov/pubmed/25684013
http://dx.doi.org/10.3349/ymj.2015.56.2.582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329376/
https://www.ncbi.nlm.nih.gov/pubmed/25684013
http://dx.doi.org/10.3349/ymj.2015.56.2.582

Ejemplares similares